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The Cmr complex is an RNA-guided effector
complex that cleaves invader RNA in the prokaryotic
immune response mediated by the CRISPR (Clus-
tered Regularly Interspaced Short Palindromic
Repeat)-Cas system. Here, we report the crystal
structure of a Cmr subcomplex containing Cmr2
(Cas10) and Cmr3 subunits at 2.8 A˚ resolution. The
structure revealed a dual ferredoxin fold and
glycine-rich loops characteristic of previously known
repeat-associated mysterious proteins and two
unique insertion elements in Cmr3 that mediate its
interaction with Cmr2. Surprisingly, while mutation
of both insertion elements significantly weakened
Cmr3-Cmr2 interaction, they exhibit differential
effects on Cmr-mediated RNA cleavage by the Cmr
complex, suggesting stabilization of Cmr2-Cmr3 in-
teractions by other subunits. Further mutational
analysis of the two conserved (but non-Cmr2-
binding) glycine-rich loopsofCmr3 identified a region
that is likely involved in assembly or the RNA
cleavage function of the Cmr complex.
INTRODUCTION
Microorganisms are challenged by viruses, plasmids, and
other mobile genetic elements that can threaten their survival.
Therefore, bacteria and archaea have developed strategies for
defending themselves against the invading nucleic acids of
these molecular parasites. Clustered regularly interspaced short
palindromic repeats (CRISPR)-CRISPR-associated (Cas) sys-
tems provide host cells with a mechanism that captures inherit-
able memory of an infection and uses the information to disable
the invasive agents (Bhaya et al., 2011; Makarova et al., 2011a;
Terns and Terns, 2011; Wiedenheft et al., 2012). CRISPRs are
genetic loci of identical repeats interspaced with distinct spacer
or guide sequences derived from genetic elements of past
invaders (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al.,
2005). A set of protein-encoding genes typically found immedi-
ately adjacent to the repeat-spacer array direct the synthesis376 Structure 21, 376–384, March 5, 2013 ª2013 Elsevier Ltd All righof Cas proteins. Together, the transcribed CRISPR repeat-
spacer array and Cas proteins provide an RNA-mediated
defense mechanism against the invaders (Haft et al., 2005;
Makarova et al., 2011a).
CRISPR immunity is characterized by three functional stages.
In the adaptation stage, infected cells incorporate a small portion
of the invader’s genetic sequence (30 base pairs) into their
genome as a ‘‘spacer’’ by largely unknownmechanisms (Barran-
gou et al., 2007; Datsenko et al., 2012; Erdmann and Garrett,
2012; Garneau et al., 2010; Horvath et al., 2008; Swarts et al.,
2012; Yosef et al., 2012). In the biogenesis stage, the CRISPR
repeat-spacer array is transcribed and processed to yield small
CRISPR RNAs (crRNA), each of which is comprised of a spacer
sequence and some repeat sequence (Brouns et al., 2008; Carte
et al., 2008; Hale et al., 2008; Haurwitz et al., 2010; Sashital
et al., 2011; Gesner et al., 2011). Finally, in the silencing stage,
crRNAs assemble with Cas proteins and guide the ribonucleo-
protein particles to degrade (or otherwise silence) invading
nucleic acids (Hale et al., 2009; Jinek et al., 2012; Westra et al.,
2012; Zhang et al., 2012).
There are ten or more CRISPR-Cas systems that are catego-
rized into three superfamilies based primarily on bioinformatic
analysis of cas genes. Type I CRISPR-Cas systems, exemplified
by the Cse system of Escherichia coli (E. coli), use specific
ribonucleases to process crRNA (Brouns et al., 2008). A
multi-subunit ribonucleoprotein complex comprised of Cse
proteins and crRNA recognizes invading nucleic acids by
complementary base-pairing and recruits a helicase-nuclease,
Cas3, to cleave the invader (Jore et al., 2011; Lintner et al.,
2011; Westra et al., 2012; Wiedenheft et al., 2011). Type II
CRISPR-Cas systems such as the Csn systems of Strepto-
coccus thermophilus and Streptococcus pyogenes use
a trans-activating CRISPR RNA (tracrRNA) and non-Cas protein,
RNase III, to process crRNA, and the dual active site nuclease
Cas9 protein for cleaving nucleic acid targets (Deltcheva et al.,
2011; Garneau et al., 2010; Jinek et al., 2012). Type III
CRISPR-Cas systems also use sequence-specific ribonucle-
ases for processing crRNA but a crRNP complex containing
a polymerase/nucleotide cyclase-like Cas10 protein for destruc-
tion (Hale et al., 2009, 2012; Zhang et al., 2012; Zhu and Ye,
2012). For both the biogenesis and silencing processes, where
biochemical mechanisms have been determined, a diverse
range of Cas protein types have been observed to serve the
same functional roles. However, while the protein compositionts reserved
Table 1. Data Collection and Refinement Statistics
Cmr2dHD-Cmr3-ATP
Space group I222
a 102.5
b 135.9
c 189.6
Resolution range (A˚) 50.0–2.85 (2.90–2.85)
No. of observed unique
reflections
32647 (1557)
Redundancy 8.0 (6.6)
Completeness (%) 99.9 (99.9)
I/s (I) 33.1 (2.5)
Rsym (%) 8.1 (75.9)
Refinement statistics
Resolution range (A˚) 36.833–2.804
Rwork (%) 23.2
Rfree (%) 26.8
Root-mean-square deviations
Bond length (A˚) 0.008
Bond angle () 1.146
Ramachandran plot of protein residues
Preferred regions (%) 94.7
Allowed region (%) 5.3
Disallowed region (%) 0
Values in parentheses are for the highest resolution shell.
Structure
Structure of the Cmr2-Cmr3 Subcomplexand mechanism of action differ significantly between type I and
III effector complexes, both include members of the repeat-
associated mysterious protein (RAMP) family, suggesting an
evolutionary link among the seemingly diverse CRISPR-Cas
systems. Structures of the RAMP proteins studied so far re-
vealed a common dual-ferredoxin fold capable of binding
(Wang et al., 2012), and in some cases (the CRISPR RNA endor-
ibonucleases) cleaving RNA (Carte et al., 2008; Haurwitz et al.,
2010; Laronde-Leblanc, 2012; Nam et al., 2012; Sashital et al.,
2011; Sternberg et al., 2012). There are currently no data on
how RAMP proteins partner with other Cas proteins in the
assembly of the various CRISPR-Cas complexes. Structure
and function studies of Cas proteins and their complexes are
required for a complete understanding of the CRISPR-Cas
immune systems.
The Cmr complexes of P. furiosus (Pf) and S. solfataricus (Ss)
have been well characterized biochemically and they serve as
models for studies of type III subtype B (IIIB) CRISPR-Cas
systems (Hale et al., 2009, 2012; Zhang et al., 2012). The Pf
Cmr complex contains six proteins (Cmr1-Cmr6) that copurify
with crRNAs of two sizes (39nt and 45nt) (Hale et al., 2009,
2012). The Cmr complex crRNAs consist of 8-nt of repeat
sequence and 31-nt or 37-nt of guide sequence. While the guide
sequence is used to bind target RNA through base-pairing, the
8-nt tag sequence is thought to serve as the anchor with which
the Cmr proteins associate specifically. Upon recognition of
a target RNA, the Cmr complex cleaves at the 14th based-paired
nucleotide of the target RNA. Although the cleavage activity is
metal-dependent, the cleavage products contain 50-OH andStructure 21,30-phosphate or 20,30-cyclic phosphate groups, suggesting
a metal-independent catalytic mechanism (Hale et al., 2009).
The molecular details of how the Cmr complex interacts with
the crRNA and destroys the target RNA remain largely unknown.
We have begun to elucidate functional roles of each Cmr
protein by using in vitro reconstituted Pf Cmr complexes. Previ-
ously, we studied structure and function of the hallmark Cas10
subunit, Cmr2 (Cocozaki et al., 2012). Deletion or mutation of
two previously predicted nuclease active sites of Cmr2 (the
N-terminal putative histidine-aspartate [HD] domain and an
internal, highly conserved aspartate [GGDD] cluster) did not
affect target RNA cleavage by the Cmr complex, indicating
that Cmr2 is not likely the catalytic component of the Cmr
complex (Cocozaki et al., 2012; Makarova et al., 2002). This rai-
ses the question of where the ribonuclease activity resides
among the Cmr subunits. The fact that four of the six Cmr
proteins, Cmr1, Cmr3, Cmr4, and Cmr6, belong to the RAMP
family of Cas proteins whose members include crRNA process-
ing endoribonucleases, suggests that one of these four essential
proteins could possess the catalytic site. In this work, we report
the structure of Pf Cmr3 bound with the HD-domain-deleted
Cmr2 (Cmr2dHD) and ATP at 2.8 A˚ resolution. We show that
Cmr3 structurally resembles crRNA processing endonucleases
Cas6 (Wang et al., 2011) and Cse3 (Brouns et al., 2008; Gesner
et al., 2011; Sashital et al., 2011). Together with mutagenesis
analysis, we have identified important functional regions in
Cmr3 required for binding Cmr2 and possibly for subsequent
steps in the Cmr complex function.RESULTS
Untagged Pf Cmr3 (Pf1128) was co-purified as a 1:1 complex
with an N-terminally tagged Pf Cmr2dHD (Pf1129) lacking the
N-terminal HD domain (residues 1–212) (Cocozaki et al., 2012).
The Cmr2dHD-Cmr3 complex was crystallized in space group
I222 with one protein complex in the asymmetric unit. Since
Cmr2dHD had previously been shown to interact with an
adenine nucleotide, the crystals were soaked in a solution
containing ATP prior to diffraction. The structure of the
Cmr2dHD-Cmr3-ATP complex was solved by single wavelength
anomalous diffraction (SAD) phasing using a crystal containing
selenomethionine-labeled Cmr2dHD. The structure was refined
to an Rwork of 21.4% and an Rfree of 26.4%. The structure of
the Cmr2dHD-Cmr3-ATP complex contains Cmr2 residues
213–402, 415–559, 569–608, 638–819, and 824–871 and Cmr3
residues 3–11, 32–48, 61–141, and 170–321. Data collection,
phasing, and refinement statistics are presented in Table 1.Cmr3 Shares Structural Homology with other RAMP
Proteins
Cmr3 has three domains: two ferredoxin fold domains (FxN
and FxC) and an insertion domain (I) (Figures 1A and 1B). The
two ferredoxin domains are arranged similarly to those in the
crRNA processing endoribonuclease members of the RAMP
family (Przybilski et al., 2011; Sashital et al., 2011; Wang
et al., 2011). Although structural disorder is observed in three
regions of Cmr3 (Leu12-Ile31, Lys49-Glu60, and Glu142-
Leu169), it still is evident that Cmr30s FxN domain follows376–384, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 377
Figure 1. Structure and Topology of Cmr3
when Bound to Cmr2dHD
(A) Secondary and domain structures of Cmr3 in
two orientations. ‘‘FxN’’ and ‘‘FxC’’ refer to the
ferredoxin folds of the N-terminal and C-terminal
domains and ‘‘I’’ refers to the insertion domain.
Cmr3 domains are shown in different colors (FxN,
yellow; FxC, light green; I, purple).
(B) Topology of the Cmr3 structure. The two
glycine-rich loops are shown in red. ‘‘N-Gloop’’
refers to the glycine-rich loop of the N-terminal
domain and ‘‘C-Gloop’’ refers to the glycine-rich
loop of the C-terminal domain.
See also Figure S1.
Structure
Structure of the Cmr2-Cmr3 Subcomplexa classic babbab topology (b1a1b2b10a3b11), suggesting a great
stability of the ferredoxin fold itself (Figure 1B).
Both the FxN and FxC domains include secondary structure
appendages to the basic babbab fold (Figures 1A and 1B). The
previously predicted glycine-rich loop (G-loop) near the end of
the FxN domain (Makarova et al., 2011a) is well ordered between
a3 and b11 (Figures 1A and1B). The insertion domain is the largest
addition to the FxN domain (Figures 1A and 1B). This domain
(Thr74-Ile141) emanates from the second and returns to the third
b strand of the FxN fold. The insertion domain is composed of
three nearly isolated b strand units (b3b8, b9b4b5, and b6b7) and
a single helix (a2). It rests on the flat b sheet surface of the FxC
domain and is also stabilized by the bound Cmr2dHD protein
(Figures 3A and 3C). The isolated b strands of the insertion
domain are stabilized by their interactions with both the FxC
domain and Cmr2dHD. In the absence of these interactions,
these b strands are likely to be disordered. The insertion domain
is essential to the integrity of the Cmr3 structure; its removal was
detrimental to the solubility of Cmr3 (data not shown).
The FxC domain is connected to the FxN domain through
a nonconserved linker (Lys211-Lys224) (Figure 1A; Figure S1
available online). The FxC domain has a degenerate babbab
topology (b12a5b13b16b18) with the second a-helix replaced by
a long b-hairpin (b14-b15, residues Ser260-Pro285). The se-
quence of the b-hairpin is well conserved (Figure S1), which is
consistent with its role in mediating Cmr2dHD-Cmr3 interac-
tions (discussed below). The FxC domain ends with another
G-loop, characteristic of RAMP proteins. As in other RAMP378 Structure 21, 376–384, March 5, 2013 ª2013 Elsevier Ltd All rights reservedproteins, the FxC G-loop is positioned
between the two ferredoxin domains,
suggesting its role in maintaining folding
integrity of RAMP proteins (Figure 1A).
The structure of Pf Cmr3 was com-
pared with other known protein struc-
tures using the DALI server search. The
RAMP superfamily endoribonucleases
Cas6 (3PKM) and Cse3 (2Y8W) emerged
as the two top structural homologs.
Despite low sequence homology (10%–
12% sequence identity) with Cas6
(Wang et al., 2011) and Cse3 (Sashital
et al., 2011), Cmr3 has a root-means-
square-deviation (RMSD) of 3.4 A˚ (155
aligned Ca) and 4.3 A˚ (155 aligned Ca)for Cas6 (3PKM) and Cse3 (2Y8W), respectively (Figure 2). Align-
ments of Cmr3 to other RAMP proteins were limited to the ferre-
doxin folds (Figure 2).
Interestingly, although the structure of Cmr3 was obtained
without bound RNA, it is more similar to the RNA-bound than
the isolated forms of Cas6 and Cse3. This is largely due to the
b-hairpin of the FxC domain in all three structures (Figure 2). In
both Cas6 and Cse3, the b-hairpin is used to bind RNA (Sashital
et al., 2011;Wang et al., 2011), and in Cmr3 it interacts with Cmr2
(Figure 3). In the RNA-unbound structures of Cas6 and Cse3, the
b-hairpin is unstructured (Sashital et al., 2011; Wang et al., 2011)
rendering the lower similarity between those structures and that
of Cmr2dHD-bound Cmr3. This comparison suggests that the
FxC domain provides a basic framework for insertion elements
that serve the function of protein-protein or protein-RNA
interaction.
Overall Structure of the Cmr2dHD-Cmr3 Complex
The structural features of isolated Pf Cmr2dHD bound to ADP
were previously described (Cocozaki et al., 2012). Briefly,
Cmr2dHD is composed of four domains (D1–D4) that form an
overall flat triangular shape. Domains D1 and D3, both of the
ferredoxin fold, form a homodimeric nucleotide-cyclase-like
arrangement. In addition, D1 contains a conserved zinc-finger
subdomain while D3 contains a highly conserved GGDD motif
that is part of a binding site for divalent metals and ADP (Coco-
zaki et al., 2012). Cmr3 binds to Cmr2dHD through extensive
interactions with the C terminus of the D1 domain (Figures 3A
Figure 2. Structure Comparison
Comparison of the structure of Pyrococcus fur-
iosus Cmr3 with those of RNA-bound Pyrococcus
furiosus Cas6 (3PKM) (Wang et al., 2011) and
Thermus thermophilus Cse3 (2Y8W) (Sashital
et al., 2011). Superimposed protein structures are
displayed in separate panels for clarity. Ferredoxin
folds of the three proteins are shown in orange
and their appendages are shown in violet for
Cmr3, green for Cas6, and cyan for Cse3. The
N-terminal and C-terminal glycine-rich loops are
shown in red.
Structure
Structure of the Cmr2-Cmr3 Subcomplexand 3C). There are no contacts made between Cmr3 and the D2,
D3, or the D4 domain of Cmr2dHD. Computed surface electro-
static potential showed that the Cmr2dHD-Cmr3 complex
contains basic patches on surfaces of Cmr3 as well as that of
a pocket formed between Cmr2dHD and Cmr3 (Figures 3B
and 3D), suggesting potential sites of interaction with RNA.
Similar to the structure of isolated Cmr2dHD, that of the
Cmr2dHD in complex with Cmr3 contains a single ATP molecule
bound at its nucleotide-binding site between the D1 and D3
domains (Figures 3A and 3C). The bound Cmr3 is approximately
5 A˚ away from the ATP and partially blocks its access to solvent
(Figures 3A and 3C). The fact that no direct contacts are
observed between Cmr3 and the bound ATP suggests that
Cmr3 does not directly facilitate ATP-binding, although it may
stabilize it through its interaction with Cmr2dHD.
Cmr3 Binds to Cmr2dHD Using Appendages to Its
Ferredoxin Folds
Analysis of the accessible surface area of Cmr2dHD and Cmr3
alone and as a complex using the Protein Interfaces, Surfaces
and Assemblies (PISA) server revealed a moderate 1672 A˚2 of
buried surface area comprising 57% polar and 43% nonpolar
residues. Residues at the interface between Cmr2dHD and
Cmr3 are only marginally conserved. Cmr3 contributes 43 resi-
dues, primarily from its insertion domain and b14-b15 hairpin,
while Cmr2dHD contributes 45 residues from the C terminus of
its D1 domain to the interface.
Protein-protein interactions provide mutual stabilization to
both Cmr3 and Cmr2dHD. Clear structural changes are
observed for Cmr2 upon binding to Cmr3. In the unbound
Cmr2dHD, residues Asp377-Ala402 and Arg436-Lys444
showed no electron density (Cocozaki et al., 2012). Upon binding
Cmr3, Asp377-Ala402 of Cmr2 form well-ordered secondary
structures that include a9’ and a10’ between b3 and a9, while resi-
dues Arg436-Lys444 form the C-terminal portion of a9 and a loop
that connects a9 to the zinc finger motif (Figure 4). In addition,
Lys606-Ile608 of the b4-a18 loop and Phe699-Gly707 of the
a19-b7 loop of Cmr2dHD were also disordered in the isolated
Cmr2 structure (Cocozaki et al., 2012), but become structured
upon binding to Cmr3 (Figure 4). In addition, unbound Cmr3 is
highly insoluble (data not shown) indicating that the structure
of Cmr3 is stabilized upon association with Cmr2dHD.
Cmr3 mainly uses insertions to the ferredoxin folds to
interact with the N-terminal D1 domain Cmr2dHD. Cmr3 bindsStructure 21,to Cmr2dHD via the b6-b7 hairpin of its insertion domain, and
the first bab unit and the long inserted b14-b15 hairpin of the
C-terminal ferredoxin fold. The b6-b7 hairpin loop of Cmr3 wraps
around the a9 helix of Cmr2dHD, and at the same time, makes
contact with a newly observed a10
0 a-helix of Cmr2dHD
(Ser377-Glu404), leading to formation of a hydrophobic core
at the interface. Phe100 of Cmr3 (Figure S1) packs into this
hydrophobic pocket (Figure 4). Contacts with a9 of Cmr2dHD
are also made from a5 and b13 of the first bab unit of the FxC
domain, although these contacts are primarily nonspecific.
The side chain of Phe437 of Cmr2dHD, which is unstructured
in the free Cmr2dHD structure and exposed to solvent,
packs against a hydrophobic patch formed by residues
from the C-terminal ferredoxin domain of Cmr3 (Figure 4).
Phe437 is conserved in sequence as a bulky hydrophobic
residue (Phe or Ile). However, the sequences of both Cmr3
and Cmr2dHD are mostly nonconserved in this region. The
long b14-b15 hairpin of Cmr3 runs parallel to the mostly noncon-
served loop following the a9 helix of Cmr2dHD, with which it
makes multiple polar and nonpolar interactions. In particular,
three pairs of conserved salt bridges are formed by Cmr3-
Lys280 and Cmr2dHD-Glu441, Cmr3-Asp270 and Cmr2dHD-
Lys444, and Cmr3-Thr279 and Cmr2dHD-Glu442 (Figures 4
and S1). These results suggest that RAMP proteins utilize
appendages to their ferredoxin folds for interactions with other
proteins.
Functional Importance of Cmr3 Structural Elements
Cmr3 and four of the other five Cmr proteins (Cmr1, Cmr2, Cmr4,
and Cmr6) are required for RNA-guided RNA cleavage (Hale
et al., 2009). To assess the role of Cmr3 in assembly of functional
complexes and target RNA cleavage, we performed mutagen-
esis analysis guided by the Cmr3-Cmr2dHD complex structure
(Figure 5A). We first assessed the role of the Cmr2-interacting
elements in Cmr3 (Figure 5A). We deleted part of the b6-b7
(Asn96-Ile105) (db6-b7) or b14-b15 (Ser267-Lys277) (db14-b15)
hairpins and tested for interaction with Cmr2dHD in copurifica-
tion assays. As expected, both mutations severely disrupted
interaction with Cmr2 (Figure 5B). Interestingly however, when
tested in cleavage assays in the presence of added Cmr2dHD
and the other Cmr proteins, while the db14-b15 mutant does not
support RNA cleavage, complexes assembled with the db6-b7
mutant are functional (Figure 5C). Consistent with the lack of
conservation at the b6-b7 loop and the sequence conservation376–384, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 379
Figure 3. Overall Structure of the
Cmr2dHD-Cmr3-ATP Complex of Pyrococ-
cus furiosus
(A) Ribbons representation of the Cmr2dHD-
Cmr3 complex with Cmr2dHD domains shown in
different colors (D1, blue; D2, green; D3, orange;
D4, red). ‘‘FxN’’ and ‘‘FxC’’ refer to the N- and
C-terminal ferredoxin folds of Cmr3, respectively,
and ‘‘I’’ refers to the insertion domain of Cmr3.
Cmr3 domains are shown in different colors (FxN,
yellow; FxC, light green; I, purple). Ordered water
molecules are shown as red spheres, Na2+ metal
ions are shown as purple spheres, and a Zn2+
metal ion bound to the zinc-finger of the D1
domain is shown as a black sphere. An ATP
molecule is represented by ball-and-stick models.
(B) Surface electrostatic potential distribution of
the Cmr2dHD-Cmr3 complex with positive
potential areas shown in blue and negative
potential areas shown in red. The complex is in the
same orientation as in (A).
(C) Cmr2dHD-Cmr3 complex structure in a differ-
ent orientation relative to that of (A).
(D) Electrostatic potential distribution of the
Cmr2dHD-Cmr3 complex in the same orientation
as in (C). For (B) and (D), the dotted lines are used
to define the surfaces of Cmr2 and Cmr3.
Structure
Structure of the Cmr2-Cmr3 Subcomplexof the b14-b15 loop, this result indicates that the interaction medi-
ated by the b14-b15 hairpin of Cmr3 is essential for the function of
the complex and that other Cmr subunits have some stabilization
effects on the db6-b7 mutant.
We then tested the functional roles of the two G-rich loops in
Cmr3, which are not observed at the Cmr2-Cmr3 interface. G-
rich loops of the RAMP superfamily protein play significant roles
in RNA binding and catalysis in the crRNA processing endoribo-
nucleases (Gesner et al., 2011; Sashital et al., 2011; Wang et al.,
2011). We deleted residues Gly198-Arg202 from the N-ferreo-
doxin G-loop to create Cmr3DN-G (Figure 5A) and substituted
Gly198 and Gly199 with Ala to create Cmr3subN-G. We also at-
tempted deleting the C-terminal G-loop or substituting its
glycines into alanines, but the resulting mutants were unstable
in our hands (data not shown). To test the importance of the
C-terminal G-loop of Cmr3, we mutated its highly conserved
Tyr313 residue to create Cmr3-Y313A. All three G-loop mutants
reconstituted fully assembled Cmr complexes. However, only
the Cmr3DN-G mutation disrupted the RNA-cleavage activity
of the complex (Figure 5D) without affecting the assembly of
the Cmr RNP (Figure S2). This may be explained by the possi-
bility that substitutions of G-loop residues are less disruptive
than deletion of its residues. Nonetheless, these results identi-
fied an important function in binding/cleaving RNA of the FxN
domain G-loop. Strikingly, the FxN G-loop is found near the
b14b15 hairpin that is also critical to Cmr complex function
(Figure 5A).
Lastly, we identified four conserved residues in Cmr3 that are
possible candidates for involvement in catalytic function: Asp10,380 Structure 21, 376–384, March 5, 2013 ª2013 Elsevier Ltd All rights reservedGlu144, Glu160, and Glu200 (Figures 5A
and S1). These acidic residues have the
potential for divalent metal coordinationas was observed with Cmr2dHD (Cocozaki et al., 2012).
However, we found that substitution of the residues did not
disrupt in vitro RNA cleavage activity (Figure 5E), thus ruling
out a direct role of these acidic residues in the catalytic process.
DISCUSSION
The Cmr complex is the effector complex of the type IIIB
CRISPR-Cas system and has been previously shown to possess
crRNA-guided RNA degradation activity (Hale et al., 2009, 2012;
Zhang et al., 2012). Biochemical studies with the P. furiosus Cmr
complex showed that the Cmr complex is comprised of six Cmr
proteins (Cmr1–Cmr6) and a crRNA, which can be one of two
size forms. Depending on the length of the crRNA, the Cmr
complex cleaves at a different site on the target RNA 14 nucleo-
tides downstream of the first paired target RNA nucleotide (Hale
et al., 2009). All six Cmr proteins are required for assembly and
cleavage of the target RNA (Hale et al., 2009). Although divalent
metals are required for RNA cleavage, the end groups of the
cleaved products are consistent with a metal-independent cata-
lytic mechanism (Hale et al., 2009). Five of the six Cmr proteins
contain features that are suggestive of direct involvement in
RNA binding and catalysis. However, functional roles of the
subunits remain to be identified.
Previously, we studied the structure and function of the hall-
mark Cas10 protein family subunit, Cmr2 (Cocozaki et al.,
2012). Our results suggest that Cmr2 may not be the catalytic
component of the Cmr complex since removal or deletion of
two conserved domains previously predicted to harbor nuclease
Figure 4. Interaction Interface between Cmr2dHD and Cmr3
Parts of Cmr2dHD that become structured after binding to Cmr3 are shown in
white. Conserved residues involved in protein-protein interactions are shown
in ball-and-stick models. Ordered water molecules are shown as red spheres,
Na2+metal ions are shown as purple spheres and a Zn2+metal ion bound to the
zinc-finger of the D1 domain is shown as a black sphere.
See also Figure S1.
Structure
Structure of the Cmr2-Cmr3 Subcomplexactive sites (the HD domain and polymerase/palm-like domain
that binds both ATP and divalent ions) do not affect target RNA
cleavage (Cocozaki et al., 2012). Here, we demonstrated a direct
interaction betweenCmr2 andCmr3. Cmr3 belongs to the RAMP
superfamily of proteins whose members include endoribonu-
cleases. We determined a 2.8 A˚ resolution structure of the
Cmr2dHD-Cmr3-ATP complex and performed mutagenesis to
probe the observed structural features of Cmr3 and its function.
We showed that Cmr3 resembles the endoribonuclease RAMP
proteins structurally, but has evolved unique insertion elements
that are critical for the function of the Cmr complex. Interestingly,Structure 21,the interaction interface containsmostly nonconserved elements
of Cmr3 and Cmr2dHD with the exception of the b14-b15 hairpin
of Cmr3. This suggests evolutionary plasticity at the interaction
interface between the two proteins. The two structural elements
of Cmr3 where we found that mutation disrupts the function of
the complex, the b14-b15 hairpin and FxN G-loop, are located
near each other in the structure. The b14-b15 hairpin mediates
the interaction of Cmr3 with Cmr2. Our findings suggest that
the b14-b15 hairpin / FxN G-loop region of Cmr3 may be involved
in multiple important interactions.
Four of the six Cmr proteins belong to the RAMP superfamily
of proteins (Hale et al., 2009). RAMP proteins are ubiquitous in
CRISPR systems and participate in both the biogenesis and
silencing phases of the immune response (Hale et al., 2009;
Jore et al., 2011; Makarova et al., 2011a; Przybilski et al.,
2011). RAMP proteins are found in eight of the ten subtypes of
CRISPR systems including all subtypes of the type I and type
III CRISPR systems (Makarova et al., 2011b). Similarly to
RAMP proteins, Cmr2 also contains two RRM-like folds (Coco-
zaki et al., 2012). The fact that the structure of Cmr3 resembles
the crRNA processing endoribonucleases supports the notion
that all RAMPproteins have a similar structural fold. Interestingly,
unique insertions to the basic babbab topology in Cmr3
mediate protein-protein (and perhaps RNA-binding) functions.
The Cmr2dHD-Cmr3 structure provides a working model to
understand the assembly of CRISPR-Cas complexes containing
RAMP superfamily proteins.EXPERIMENTAL PROCEDURES
Protein Preparation and Crystallization
The Cm2dHD protein was constructed as described (Cocozaki et al., 2012).
The Cmr2dHD (N-terminal poly-histidine tagged) and Cmr3 (untagged)
proteins were expressed separately in Escherichia coliBL21 RIPL cells (Agilent
technologies, Santa Clara, CA). Cell pellets were combined and resuspended
in a lysis buffer (25 mM sodium phosphate pH 7.5, 1.0 M NaCl, 10% [v/v] glyc-
erol, 5.0 mM b-mercaptoethanol, and 0.2 mM phenylmethylsulfonyl fluoride).
The cells were lysed by sonication and their debris was cleared by centrifuga-
tion. The supernatant was loaded onto a Ni-NTA column equilibrated with the
lysis buffer supplemented with 5 mM imidazole. The column was washed with
the lysis buffer containing 25 mM imidazole and the protein was eluted by
increasing imidazole to 350 mM. Fractions containing protein were pooled
and loaded onto a Superdex 200 (Hiload 26/60, GE Healthcare) size-exclusion
chromatography column that had been equilibrated with 20 mM Tris-HCl pH
7.4, 500 mM NaCl, 5% (v/v) glycerol, and 5 mM b-mercaptoethanol. Fractions
corresponding to the Cmr3-Cmr2dHD protein complex were pooled and
concentrated. The L-selenomethionine (SeMet) labeled protein complex was
prepared by a similar procedure.
Native or SeMet-labeled complex was crystallized at 30C by using the
vapor diffusion hanging-drop method. Equal volumes of protein complex
and a 15%–22% polyethylene glycol (PEG1500) solution were combined
into 2.4 ml droplets on coverslips that were then sealed with a 21%–25%
PEG1500 solution. Crystals formed in 6-7 days and had a hexagonal prism
shape with typical dimensions of 0.4 mm 3 1 mm 3 0.4 mm.
Data Collection and Structure Determination
Crystals were cryo-protected in a buffer containing 1.5 M NaCl, 20%
PEG1500, and 2 mM adenosine triphosphate (ATP) prior to being mounted
on a goniometer head. ATP (2 mM) was included in the cryo-solution
since Cmr2dHD was previously shown to bind ADP at its nucleotide binding
site. X-ray diffraction data were collected at the Southeast Regional Collabo-
rative Access Team (SER-CAT) beamline 22ID or 22BM. Data were indexed,
integrated, and scaled using the HKL2000 software package. The space376–384, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 381
Figure 5. Functional Analysis of Cmr3
(A) Structure of the Cmr2dHD-Cmr3 complex
mapped with mutated regions shown in red.
(B) Copurification of Cmr3 loop mutants with
Cmr2dHD. Untagged Cmr2dHD and tagged Cmr3
mutant were coexpressed and copurified by
NiNTA affinity purification. For both panels, lane 1
is a molecular weight marker. Lanes 2, 3, and 4
represent steps prior to loading on the NiNTA
column and lane 5 represents the elution products
from the NiNTA column. Lane 6 is the elution from
a similar copurification experiment run in parallel
using the wild-type Cmr3. (Left) Copurification of
the db6-b7 mutant of Cmr3 with Cmr2dHD. (Right)
Copurification of the db14-b15 mutant of Cmr3 with
Cmr2dHD.
(C) RNA cleavage assay results using wild-type
(WT) and Cmr3 deletion mutants (db6-b7 and
db14-b15). Copurified Cmr3-Cmr2dHD samples
were combined with Cmr1, Cmr4, Cmr5, and
Cmr6 in the absence (Cmr2) or presence
(+Cmr2) of separately purified Cmr2dHD and
incubated with crRNA (of size 39nt or 45nt) and
radiolabeled target RNA. ‘‘-’’ denotes the control
without addition of the Cmr complex. Full triangles
indicate cleavage products. Empty triangles indi-
cate uncleaved target RNA. Asterisks indicate
crRNA-target duplexes not separated on dena-
turing polyacrylamide gel. A single cleavage
product is obtained with the 39-nt crRNA. The
smeary appearance of the band is the result of the
mildly denaturing conditions of the acrylamide gel.
(D) RNA cleavage assay results using the
N-terminal deletion (DN-G) and N-terminal G-A
substitution (subN-G) G-rich loop mutants as well
as the Y313Amutant of the C-terminal G-rich loop.
(E) RNA cleavage assay results using single
mutations of Cmr3. Particle reconstitution and
cleavage procedures are described in (C).
See also Figures S1 and S2.
Structure
Structure of the Cmr2-Cmr3 Subcomplexgroup of the crystals was determined to be I222 with one Cmr2dHD-Cmr3
complex in the asymmetric unit and the cell dimensions are listed in Table 1.
Phases were determined from a highly redundant single-wavelength anoma-
lous dispersion (SAD) data set at the anomalous peak of selenium from
a SeMet-labeled crystal. Structure determination, iterative model building,
and structure refinement were done using the PHENIX (Adams et al., 2010)
and COOT programs (Emsley and Cowtan, 2004). The refinement statistics
are shown in Table 1.
RNA-Cleavage Reactions
In vitro RNA cleavage assay was carried out similarly as previously described
(Hale et al., 2009). Briefly, purified Cmr proteins were combined in equal molar
amounts to a final concentration of 50 mM in 20 mM Tris-HCl (pH 7.4), 500 mM
NaCl, 5% (v/v) glycerol, and 5 mM b-mercaptoethanol. The reconstituted
complex was diluted to 1 mM before being incubated with either the 39-mer
or the 45-mer Pf7.01 crRNA (Hale et al., 2009) at 0.1 mM at 70C in 20 mM
sodium cacodylate (pH 6.2), 20 mMMgCl2 in the presence of 1 unit of SUPER-
ase-In RNase inhibitor. The RNA cleavage reaction was initiated by adding
0.016 mM 50-radiolabeled target RNA and the reaction was incubated for
1 hr at 70C. The reaction was quenched by the addition of 96% formamide
dye. The cleavage products were resolved on a 15% polyacrylamide, 7 M
urea gel, and visualized by phosphorimaging.382 Structure 21, 376–384, March 5, 2013 ª2013 Elsevier Ltd All righACCESSION NUMBERS
The Protein Data Bank accession number for the Cmr2-Cmr3 complex re-
ported in this paper is 4H4K.
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